These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33810966)

  • 1. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
    Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
    Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
    Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
    Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
    Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: A retrospective cohort study from the China Health and Retirement Longitudinal Study.
    Wu Y; Wang H; Tong Y; Zhang X; Long Y; Li Q; Ren J; Liu C
    Front Public Health; 2023; 11():1122922. PubMed ID: 37026117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
    Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P
    Respiration; 2019; 97(4):302-309. PubMed ID: 30481791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of a 'sarcopenia index' based on serum biomarkers creatinine and cystatin C in 458,702 UK Biobank participants.
    Wilkinson TJ; Baker LA; Watson EL; Smith AC; Yates T
    Clin Nutr ESPEN; 2024 Oct; 63():207-213. PubMed ID: 38968079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
    Zhao X; Su R; Hu R; Chen Y; Xu X; Yuan Y; Zhang J; Zhang W; Yang Y; Chen M; Li D; Wu B; Huang D; Wu D
    BMC Geriatr; 2023 Feb; 23(1):89. PubMed ID: 36774462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of sarcopenia on major adverse cardiac events among patients who underwent successful percutaneous coronary intervention: a retrospective cohort study.
    Won MH; Yun KH; Kim H; Son YJ
    Eur J Cardiovasc Nurs; 2024 Apr; 23(3):287-295. PubMed ID: 37579073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
    Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
    Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
    Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
    Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
    Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer.
    Yang J; Zhang T; Feng D; Dai X; Lv T; Wang X; Gong J; Zhu W; Li J
    Colorectal Dis; 2019 May; 21(5):538-547. PubMed ID: 30648340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.
    Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K
    Int J Clin Oncol; 2024 Jul; 29(7):1002-1011. PubMed ID: 38683456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
    Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
    Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease.
    Doğaner YÇ; Aydoğan Ü; Rohrer JE; Aydoğdu A; Çaycı T; Barçın C; Sağlam K
    Anatol J Cardiol; 2015 Jul; 15(7):571-6. PubMed ID: 25537999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
    Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes.
    Hou L; Chen X; Zhu C
    Front Public Health; 2023; 11():1049738. PubMed ID: 37841730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
    Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
    Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.